
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Gelsolin CRISPR/Cas9 KO Plasmid (h) | sc-401005 | 20 µg | $397.00 |
GSN encodes gelsolin, a calcium-regulated actin-binding protein that severs and caps actin filaments to control cytoskeletal remodeling and cell mechanics. Through modulation of actin polymerization dynamics, gelsolin contributes to processes including cell motility, adhesion, endocytosis, and apoptosis, and it interfaces with signaling pathways that govern stress responses and membrane trafficking. Altered GSN expression or gelsolin activity has been associated with changes in tissue remodeling and inflammatory microenvironments, and is frequently studied in the context of cancer cell invasion, neurodegeneration, and cardiovascular biology. As a key regulator of actin filament turnover, gelsolin provides a tractable node for dissecting actin-dependent phenotypes across diverse human cell models.
Gelsolin CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the GSN gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the GSN together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the GSN open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish Gelsolin protein expression.
This CRISPR knockout system enables efficient generation of GSN-deficient cell models for investigation of Gelsolin signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.